Becker's Healthcare July 30, 2024
CMS is implementing a voluntary demonstration program designed to test policy changes to stabilize premiums year to year for Medicare Part D enrollees.
The demonstration aims to stabilize prices for enrollees while the most significant changes to the Part D program since its creation in 2006 are implemented, according to a CMS fact sheet published July 29.
In 2025, several provisions in the Inflation Reduction Act will take effect. Prescription drug costs for Medicare beneficiaries will be capped at $2,000 annually, and beneficiaries will be able to spread the costs of expensive drugs in smaller payments throughout the year.
Here are five things to know:
- Participation in the premium stabilization program is voluntary for plans....
Today's Sponsors
Today's Sponsor